Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression

被引:128
作者
Héroult, M [1 ]
Schaffner, F [1 ]
Augustin, HG [1 ]
机构
[1] Tumor Biol Ctr, Dept Vasc Biol & Angiogenesis Res, D-79106 Freiburg, Germany
关键词
endothelial cell; angiogenesis; Eph; ephrin;
D O I
10.1016/j.yexcr.2005.10.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Eph receptors comprise the largest family of receptor tyrosine kinases. They are classified into an A family and a B family on the basis of the characteristic properties of the corresponding ephrin ligands which are either GPI-anchored peripheral membrane molecules (A class ephrins) or transmembrane molecules (13 class ephrins). Eph receptors and ephrin ligands were originally identified as neuronal pathfinding molecules. Yet, gene targeting experiments in mice have identified the EphB/ephrinB system as critical and rate-limiting determinant of arterio-venous differentiation during embryonic vascular development. Identification of vascular EphB/ephrinB functions has in the last few years stimulated two emerging fields of vascular biology research, namely (1) the molecular analysis of the structural and functional mechanisms of arterio-venous differentiation, and (2) the molecular study of the commonalities between vascular and neuronal guidance and patterning mechanisms. This review summarizes the current understanding of vascular Eph receptor and ephrin ligand functions and provides an overview of emerging roles of the Eph/ephrin system in controlling tumor and vascular functions during tumorigenesis and tumor progression. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:642 / 650
页数:9
相关论文
共 82 条
[1]   The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration [J].
Adams, RH ;
Diella, F ;
Hennig, S ;
Helmbacher, F ;
Deutsch, U ;
Klein, R .
CELL, 2001, 104 (01) :57-69
[2]   Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis [J].
Adams, RH ;
Wilkinson, GA ;
Weiss, C ;
Diella, F ;
Gale, NW ;
Deutsch, U ;
Risau, W ;
Klein, R .
GENES & DEVELOPMENT, 1999, 13 (03) :295-306
[3]   The role of CXCL12 in the organ-specific process of artery formation [J].
Ara, T ;
Tokoyoda, K ;
Okamoto, R ;
Koni, PA ;
Nagasawa, T .
BLOOD, 2005, 105 (08) :3155-3161
[4]   EphB receptor activity suppresses colorectal cancer progression [J].
Batlle, E ;
Bacani, J ;
Begthel, H ;
Jonkeer, S ;
Gregorieff, A ;
van de Born, M ;
Malats, N ;
Sancho, E ;
Boon, E ;
Pawson, T ;
Gallinger, S ;
Pals, S ;
Clevers, H .
NATURE, 2005, 435 (7045) :1126-1130
[5]   β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB [J].
Batlle, E ;
Henderson, JT ;
Beghtel, H ;
van den Born, MMW ;
Sancho, E ;
Huls, G ;
Meeldijk, J ;
Robertson, J ;
van de Wetering, M ;
Pawson, T ;
Clevers, H .
CELL, 2002, 111 (02) :251-263
[6]  
Berclaz G, 2002, ONCOL REP, V9, P985
[7]   Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo [J].
Brantley, DM ;
Cheng, N ;
Thompson, EJ ;
Lin, Q ;
Brekken, RA ;
Thorpe, PE ;
Muraoka, RS ;
Cerretti, DP ;
Pozzi, A ;
Jackson, D ;
Lin, C ;
Chen, J .
ONCOGENE, 2002, 21 (46) :7011-7026
[8]   Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression [J].
Brantley-Sieders, DM ;
Fang, WB ;
Hicks, DJ ;
Zhuang, GL ;
Yu, S ;
Chen, J .
FASEB JOURNAL, 2005, 19 (11) :1884-+
[9]   EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation [J].
Brantley-Sieders, DM ;
Caughron, J ;
Hicks, D ;
Pozzi, A ;
Ruiz, JC ;
Chen, J .
JOURNAL OF CELL SCIENCE, 2004, 117 (10) :2037-2049
[10]  
BURGER PC, 1983, LAB INVEST, V48, P169